X-linked mental retardation

Medical Science Monitor

Volumn 14, Issue 11, 2008, Pages

  Lisik, Małgorzata Zofia ^a   Sieron, Aleksander L ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Nonsyndromic X linked mental retardation; Syndromic X linked mental retardation; X linked mental retardation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

COMPARATIVE GENOMIC HYBRIDIZATION; FRAGILE X SYNDROME; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC COUNSELING; GENETIC VARIABILITY; HUMAN; MOLECULAR CLONING; PHENOTYPE; REVIEW; RISK FACTOR; X LINKED MENTAL RETARDATION;

ANIMALS; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; MENTAL RETARDATION, X-LINKED; MUTATION; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 55549145060     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. WHO. The ICD-10 classification of mental and behavioral disorders. WHO: 1992
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-IV: American Psychiatric Association: 1994
3. Leonard H, Wen X: The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disab Res Rev, 2002; 8: 117-34
4. Penrose L: A clinical study and genetic study of 1280 cases of mental defect. HMSO, 1938; 229
5. Lehrke RG: X-linked mental retardation and verbal disability. Birth Defects, 1974; 10: 1-100
6. van Buggenhout GJ, Trommelen JCM, Brunner HG et al: Clinical etiological survey of a population of 471 mentally retarded patients living in an institution in the Southern part of Netherlands. Community Genet, 2001; 4: 109-22
7. Turner G: Finding genes on the X chromosome by which homo may have become sapiens. Am J Hum Genet, 1996; 58: 1109-10
8. Chelly J, Mandel JL: Monogenic causes of X-linked mental retardation. Nat Rev Genet, 2001; 2: 669-80
9. Herbst DS, Miller JR: Nonspecific X-linked mental retardation II: the frequency in British Columbia. Am J Med Genet, 1980; 7: 461-69
10. Skuse DH: X-linked genes and mental functioning. Hum Mol Genet, 2005; 14: R27-32
11. Ross MT, Grafham DV, Coffey AJ et al: The DNA sequence of the human X chromosome. Nature, 2005; 434: 325-37
12. Kerr B, Turner G, Mulley J et al: Non-specific mental retardation. J Med Genet, 1991; 28: 378-82
13. Gecz J, Mulley J: Genes for cognitive function: developments on the X. Genome Res, 2000; 10: 157-63
14. Fishburn J, Turner G, Daniel A, Brookwell R: The diagnosis and frequency of X-linked conditions in a cohort of moderately retarded males with affected brothers. Am J Med Genet, 1983; 14: 713-24
15. Ramakers GJA: Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci, 2002; 25: 191-99
16. de Brouver AP, Yntema HG, Kleefstra T et al: Mutation frequencies of X-linked mental retardation genes in families from the EuroMRX consortium. Hum Mut, 2007; 28: 207-8
17. Ropers HH, Hoeltzenbein M, Kalscheuer V et al: Nonsyndromic X-linked mental retardation: where are the missing mutations? Trends in Genetics, 2003; 19: 316-21
18. Raymond FL: X-linked mental retardation: a clinical guide. J Med Genet, 2005; 43: 193-200
19. Raymond FL, Tarpey P: The genetics of mental retardation. Hum Mol Genet, 2006; 15: R110-16
20. Lugtenberg D, Veltman JA, van Bokhoven H: High-resolution genomic microarrays for X-linked mental retardation. Genetics in Medicine, 2007; 9: 560-65
21. Froyen G, van Esch H, Bauters M et al: Detection of genomic copy number changes in patients with idiopathic mental retardation by High-Resolution X-Array-CGH: important role for increased gene dosage of XLMR genes. Hum Mut, 2007; 28: 1042-43
22. Jensen LR, Lenzner S, Moser B et al: X-linked mental retardation: a comprehensive molecular screen of 47 candidate genes from a 7,4 interval in Xp11. Eur J Hum Genet, 2007; 15: 68-75
23. Nussbaum RL, Ledbetter DH: The fragile X syndrome in: Scriver CR, Beaudet AL, Sly WS, Valle D. The metabolic and molecular bases of inherited disease. McGraw Hill Inc. New York, 1995; 795-810
24. Hagerman RJ: The physical and behavioural phenotype in: Hagerman RJ. Fragile X syndrome: Diagnosis, Treatment and Research. Johns Hopkins University Press 2002
25. Brown WT: The molecular biology of the Fragile X mutation in: Hagerman RJ. Fragile X syndrome: Diagnosis, Treatment and Research. Johns Hopkins University Press, 2002
26. Stevenson RE: Splitting and lumping in the nosology of XLMR. Am J Med Genet, 2000; 97: 174-82
27. Chiurazzi P, Hamel BCJ, Neri G: XLMR genes: update 2000. Eur J Hum Genet, 2001; 9: 71-81
28. Chiurazzi P, Tabolacci E, Neri G: X-linked mental retardation (XLMR): from clinical conditions to cloned genes. Critical Reviews in Clinical Laboratory Services, 2004; 41: 117-58
29. Stromme P, Mangelsdorf M, Shaw M et al: Mutations in the human ortholog of aristaless cause X-linked mental retardation and epilepsy. Nat Genet, 2002; 30: 441-45
30. Kato M, Das S, Petras K et al: Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum Mut, 2004; 23: 147-59
31. Renieri A, Pescucci C, Longo I et al: Non-syndromic X-linked mental retardation: from a molecular to a clinical point of view. J Cell Physiol, 2005: 204; 8-20
32. Kohn M, Steinbach P, Hameister H et al: A comparative expression analysis of four MRX genes regulating intracellular signalling via small GTPases. Eur J Hum Genet, 2004; 12: 29-37
33. Laumonnier F, Bonnet-Brilhaut F, Gomot M et al: X-linked mental retardation and autism are associated with mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet, 2004; 74: 552-57
34. Jamain S, Quach H, Betancur C et al: Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genet, 2003; 34: 27-29
35. Chelly J: Breakthroughs in molecular and cellular mechanisms underlying X-linked mental retardation. Hum Mol Genet, 1999; 10: 1833-38
36. Ropers HH, Hamel BCJ: X-linked mental retardation. Nat Rev Genet, 2005; 6: 46-57
37. van Aelst L, D'Souza-Schorey C: Rho GTPases and signaling networks. Genes Dev, 1997; 11: 2295-322
38. Hall A: Rho GTP-ases and the actin cytoskeleton. Science, 1998; 279: 509-14
39. Chechlacz M, Glesson JG: Is mental retardation a defect of synapse structure and function. Pediatr Neurol, 2003; 29: 11-17
40. Bienvenu T, des Portes V, Saint Martin A et al: Non-specific X-linked semidominant mental retardation by mutations in Rab GDP-dissociation inhibitor. Hum Mol Genet, 1998; 7: 1311-15
41. Ishizaki H, Miyoshi J, Kamiya et al: Role of Rab GDP dissociation inhibitor α in regulating plasticity of hippocampal neurotransmission. Proc Natl Acad Sci USA, 2000; 97: 1587-92
42. Trivier E, De Cesare D, Jacquot S et al: Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature, 1996; 384: 567-70
43. Petrij F, Giles RH, Dauwerse HG et al: Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature, 1995; 376: 348-51
44. Swank MW, Sweatt JD: Increased histone acetyltransferase and lysine acetyltransferase activity and biphasic activation of the ERK/RSK cascade in insular cortex during novel taste learning. J Neurosci, 2001; 21: 3383-91
45. Chelly J, Khelfaoui M, Francis F et al: Genetics and pathophysiology of mental retardation. Eur J Hum Genet, 2006; 14: 701-13
46. Merienne K, Jouquot S, Pannetier S et al: A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nature Genet, 1999; 22: 13-14
47. Couvert P, Bienvenu T, Aquaviva C et al: MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet, 2001; 10: 941-46
48. Yntenema H, Poppelaars F, Derksen E et al: Expanding phenotype of XNP mutations: Mild to moderate mental retardation. Am J Med Genet, 2002; 110: 243-47
49. Schoichet SA, Hoffman K, Menzel C et al: Mutations in the ZNF41 gene are associated with cognitive deficits: Identification of a new candidate for X-linked mental retardation. Am J Hum Genet, 2003; 73: 1341-54
50. Froyen G, Bauters M, Voet T, Marynen P: X-linked mental retardation and epigenetics. J Cell Mol Med, 2006; 10: 808-25
51. Lugtenberg D, Yntema HG, Banning MJG et al: ZNF674: A new Kruppel-Associated Box-Containing Zinc-Finger Gene involved in non-syndromic X-linked mental retardation. Am J Med Genet, 2006; 78: 265-78
52. Landomeri M, Dellaire G: Multifunctional zinc finger proteins in development and disease. Ann Hum Genet, 2002; 66: 33-42
53. Salomons GS, van Dooren SJ, Verhoewen NM et al: X-linked creatine transporter defect: an overview. J Inher Metab Dis, 2003; 26: 309-18
54. Wang Ye, Esbensen P, Bentley D: Arginine kinase expression and localisation in growth cone migration. J Neurosci, 1998; 18: 987-98
55. Gallinat S, Busche S, Raizada MK, Sumners C: The angiotensin II type 2 receptor: an enigma with multiple variations. Am J Physiol Endocrinol Metab, 2000; 278: E357-74
56. Lucius R, Gallinat S, Rosenstiel P et al: The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med, 1998; 188: 661-70
57. Rosentiel P, Gallinat S, Artl A et al: Angiotensin AT2 receptor ligands: Do they have potential as future treatments for neurological disease? CNS Drugs, 2002; 16: 145-53
58. Tarpey P, Parnau J, Blow M et al: Mutations in the DLG3 gene case nonsyndromic X-linked mental retardation. Am J Hum Genet, 2004; 75: 318-24
59. Muller BM, Kistner U, Kindler S et al: SAP102, a novel post synaptic protein that interacts with NMDA complexes in vivo. Neuron, 1996; 17: 255-66
60. Nokelainen P, Flint J: Genetic effects on human cognition: lessons from the study of mental retardation syndromes. J Neurol Neurosurg Psychiatry, 2002; 72: 287-96
61. Gecz J, Mulley J: Genes for cognitive function: developments on the X. Genome Res 2000; 10: 157-63
62. Philip N, Chabrol B, Lossi AM et al: Mutations in the oligophrenin-1 gene (OPHN1) cause X linked congenital cerebellar hypoplasia. J Med Genet, 2003; 40: 441-46
63. Higgins JJ, Topaloglu H: X-linked oligophrenic vermian dysgenesis: syndromic vs non-syndromic X-linked mental retardation? Neurology, 2005; 65: 1346-47
64. Zanni G, Saillour Y, Nagara M et al: Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia. Neurology, 2005; 65: 1364-69
65. Kleefstra T, Hamel BCJ: X-linked mental retardation: further lumping, splitting and emerging phenotypes. Clin Genet, 2005; 67: 451-67
66. Ropers HJ: X-linked mental retardation: many genes for a complex disorder. Curr Opin Genet Dev, 2006; 16: 1-10
67. Curry JC, Stevenson RE, Aughton D, Byrne J: Evaluation of mental retardation: recommendations of consensus conference. Am J Med Genet, 1997; 468-77
68. Karnebeek CDM, Jansweijer MCE, Leenders AGE et al: Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet, 2005; 13: 6-25
69. Moeschler JB, Shevell M: Clinical genetic evaluation of the child with mental retardation or developmental delay. Pediatrics, 2006; 117: 2304-16
70. Rauch A, Hoyer J, Guth S et al: Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A, 2006; 19: 839-47
71. Shevel M, Ashwal S, Donley D et al: Practice evaluation of the child with global developmental delay. Neurology, 2003; 60: 367-80
72. Frints SGM, Froyen G, Marynen P, Fryns JP: X-linked mental retardation: vanishing boundaries between non-specific (MRX) and syndromic (MRXS) forms. Clin Genet, 2002; 62: 423-32
73. Turner G, Partington M: Recurrence risk in undiagnosed mental retardation. J Med Genet, 2000; 31: 45-47
74. Crow YJ, Tolmie JL: Recurrence risks in mental retardation. J Med Genet, 1998; 35: 177-82
75. Van Naarden K, Braun K, Autry A, Boyle C: A population-based study of the recurrence of developmental disabilities - Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991-94. Pediatric and Perinatal Epidemiology, 2005; 19: 69-79